Biotech by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Scholar Rock Holding leads the 24 biotech ranked by short interest, at 19.2%, ahead of CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Scholar Rock Holding19.2%
Median
9.33%
Combined market value
PLN 3.38T
Countries
5

Market values as of .

Biotech by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Scholar Rock HoldingSRRK · Health Care19.2%PLN 21.7BPLN 177.87 1.77% down 14% up United States
2CRISPR TherapeuticsCRSP · Health Care17.7%PLN 15.8BPLN 162.59 0.81% up 21% down Switzerland
3Twist BioscienceTWST · Health Care14.4%PLN 30.3BPLN 444.19 1.27% down 340% up United States
4Kodiak SciencesKOD · Health Care12.4%PLN 25.4BPLN 387.68 0.30% down 396% up United States
5Halozyme TherapeuticsHALO · Health Care12.0%PLN 43.7BPLN 383.56 0.51% down 37% up United States
6ImmunityBioIBRX · Health Care11.9%PLN 26.6BPLN 24.99 0.64% down 193% up United States
7RepligenRGEN · Health Care11.0%PLN 42.9BPLN 670.83 2.97% up 5% up United States
8ExelixisEXEL · Health Care10.5%PLN 66.9BPLN 274.28 0.32% down 63% up United States
9CG OncologyCGON · Health Care10.3%PLN 28.7BPLN 321.36 1.34% up 85% up United States
10Krystal BiotechKRYS · Health Care10.3%PLN 35.4BPLN 1,195.44 0.32% down 46% up United States
11Kymera TherapeuticsKYMR · Health Care9.84%PLN 41.3BPLN 484.08 0.83% down 87% up United States
12VaxcytePCVX · Health Care9.70%PLN 37.7BPLN 238.12 0.20% down 22% up United States
13ImmunovantIMVT · Health Care8.96%PLN 27.7BPLN 134.09 0.51% up 43% up United States
14ModernaMRNA · Health Care8.20%PLN 333.2BPLN 823.43 0.88% down 755% up United States
15Adaptive BiotechnologiesADPT · Health Care7.09%PLN 18.6BPLN 114.60 0.14% up 88% up United States
16Revolution MedicinesRVMD · Health Care6.05%PLN 140.8BPLN 650.81 0.41% down 131% up United States
17Neurocrine BiosciencesNBIX · Health Care5.83%PLN 67.1BPLN 662.80 0.55% down 20% up United States
18Bio-TechneTECH · Health Care4.90%PLN 45.9BPLN 292.11 0.12% up 26% up United States
19BiogenBIIB · Health Care3.69%PLN 146.7BPLN 992.19 1.51% down 49% up United States
20QiagenQGEN · Health Care3.10%PLN 41.2BPLN 199.70 0.07% down 12% up Netherlands
21AmgenAMGN · Health Care2.33%PLN 980.6BPLN 1,812.89 1.45% down 34% up United States
22argenxARGX · Health Care2.25%PLN 239.3BPLN 3,805.38 0.02% down 4% up Belgium
23Gilead SciencesGILD · Health Care1.72%PLN 836.2BPLN 674.16 1.43% down 33% up United States
24BioNTechBNTX · Health Care0.91%PLN 84BPLN 338.71 0.64% down 16% down Germany

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0169 PLN).

Questions and answers

Which biotech rank first by short interest?

Scholar Rock Holding (19.2%), CRISPR Therapeutics (17.7%) and Twist Bioscience (14.4%) are the top three of the 24 biotech ranked by short interest as of the 30 Oct 2026 settlement date.

How many biotech are in this ranking?

24 are ranked by short interest.

What are these biotech worth together?

The 24 biotech ranked by short interest have a combined market value of PLN 3.38T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Biotech by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.